futurhealth semaglutide Glp-1 Weight Loss: vs Hims & Hers (Which GLP-1 Program Is Better?) What to Know About Semaglutide:

Journal of Clinical Endocrinology & Metabolism (2024) 7

The second retrospective study evaluated DILI cases diagnosed between 1994 and August 2012 and retrieved from the Spanish Hepatotoxicity Registry (REH)

Therapy with a GLP-1 RA or sodium-glucose cotransporter 2 inhibitor (SGLT2 inhibitor) that has proven CV benefit is recommended for initial therapy, with or without metformin based on glycemic needs, in patients with indicators of high-risk or established CV disease

Studies of patients on sustained GLP-1 therapy show stable weight maintenance for 2+ years, with many continuing to lose additional pounds

This discrepancy has led to confusion and dosing errors

Jardiance also has more approved indications as a treatment for heart failure and for CKD